Quantcast

Latest Pitavastatin Stories

2014-05-29 08:28:37

Kurt Warner and wife, Brenda, motivate the 71 million Americans living with high cholesterol to win big by committing to heart health NEW YORK, May 29, 2014 /PRNewswire/ -- National heart-health initiative, First and Goal, today announced the launch of a consumer sweepstakes encouraging those living with high cholesterol and their support systems to join the First and Goal Team and pledge to prioritize heart health. The Campaign is a partnership with Kurt Warner, Super Bowl champion and...

2014-05-01 08:34:19

Study results presented at the National Lipid Association Scientific Sessions 2014 ORLANDO, Fla., May 1, 2014 /PRNewswire/ -- Kowa Pharmaceuticals America, Inc. announced results of a pre-specified safety analysis from the INTREPID (HIV-infected patieNts and TREatment with PItavastatin vs. pravastatin for Dyslipidemia) trial evaluating the effect of LIVALO(®) (pitavastatin) 4 mg compared with pravastatin 40 mg in HIV-infected adults with dyslipidemia following completion of the 40-week...

2014-04-02 08:26:30

First and Goal Campaign encourages small, achievable accomplishments in cholesterol management NEW YORK, April 2, 2014 /PRNewswire/ -- Kowa Pharmaceuticals America, Inc. today announced a partnership with Kurt Warner, Super Bowl winner and two-time NFL MVP, and his wife Brenda, to launch First and Goal, a national education initiative to help people prioritize heart health. The campaign encourages the 71 million Americans living with high cholesterol to develop a personalized game plan to get...

Diabetes, Memory Loss Warnings Added to Cholesterol Medications
2012-02-29 06:16:38

The U.S. Food and Drug Administration (FDA) announced on Tuesday that they would be adding memory loss and diabetes warnings to the labels of cholesterol-lowering drugs known as statins. According to Reuters reporters Bill Berkrot and Ransdell Pierson, the label changes come after the agency learned of studies in which taking statins could lead to a small increased risk of cognitive issues such as memory loss or confusion, as well as a slight spike in blood sugar levels and the risk of...

2010-06-21 07:00:00

MONTGOMERY, Ala. and INDIANAPOLIS, June 21 /PRNewswire-FirstCall/ -- Kowa Pharmaceuticals America, Inc., and Eli Lilly and Company (NYSE: LLY) today announced that LIVALO® (pitavastatin) tablets is now available in retail pharmacies throughout the United States. LIVALO, a statin medication approved by the U.S. Food and Drug Administration (FDA) in August 2009 is indicated for adults as an adjunctive therapy to diet for the treatment of primary hyperlipidemia or mixed...

2010-03-24 16:57:00

SILVER SPRING, Md., March 24 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today approved the use of Xifaxan for reduction in the risk of the recurrence of overt hepatic encephalopathy (HE) in patients with advanced liver disease. This is a new use for Xifaxan (rifaximin), a drug that has been approved for the treatment of traveler's diarrhea. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) Hepatic encephalopathy is a worsening of brain function that can...

2009-12-23 09:52:00

INDIANAPOLIS and MONTGOMERY, Ala., Dec. 23 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S....


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'